Adamis Pharmaceuticals Corp (ADMP): Spelled Investor Incorrectly... Figured...

Reply Private New

Next 10 Prev Next

Send PM

Followers	28
Posts	1014
Boards Moderated	0
Alias Born	03/10/2014

FREE
ADMP REPORT

JJAAMMAANN

Re: JJAAMMAANN post# 2391

Friday, 03/19/2021 11:49:26 AM

Friday, March 19, 2021 11:49:26 AM

Spelled Investor Incorrectly...
Figured I'd call myself out on it before everyone else did.

In My Own Personal Opinion Of Course!

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADMP News

Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:59:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 09:48:05 PM
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/14/2022 09:10:07 PM
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 11/07/2022 09:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:16:15 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:09:16 AM
Adamis Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 10/03/2022 08:30:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/23/2022 09:08:52 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 09/23/2022 09:06:45 PM
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/21/2022 11:30:00 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/20/2022 10:03:49 AM
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/12/2022 08:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 10:05:18 AM
Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 09/09/2022 09:13:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/18/2022 07:09:02 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/15/2022 10:36:44 AM
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders • GlobeNewswire Inc. • 08/12/2022 09:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 08/10/2022 08:11:23 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 08/10/2022 08:05:21 PM
Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/10/2022 08:02:00 PM
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 08/08/2022 11:30:00 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 08/01/2022 01:38:08 PM
Dawson James Sticks to Its Hold Rating for Adamis Pharma (ADMP) • TipRanks • 07/31/2022 12:15:25 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 07/29/2022 07:36:42 PM
Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals’ Stockholders Vote FOR Critical Proposals at Upcoming Annual Meeting • GlobeNewswire Inc. • 07/29/2022 12:00:00 PM

More ADMP News

InvestorsHub NewsWire

1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM

IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM

Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM

UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM

Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM

B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

Quotes:

IHub:

Detailed Quote

Recent ADMP News

More ADMP News